What if novel drug delivery methods revolutionised medicine? [Science and Technology podcast]από Scientific Foresight (STOA)
Written by Gianluca Quaglio with Marcos Fernández Álvarez.
Nanoparticles lie at the heart of a new method for delivering medicines inside the body – and they were crucial to the success of the Covid-19 mRNA vaccines. This new drug delivery method and others could transform the way we treat disease, potentially boosting the treatment of Alzheimer's, Parkinson's and HIV, among others. Insulin and Covid-19 vaccines might even become available as pills. Can the European Union stay on top of this trend? And what challenges lie ahead?
Developing a vaccine usually takes more than 10 years. But when the Covid-19 pandemic hit, vaccines were rolled out at an unprecedented speed. China notified the WHO of a cluster of cases of pneumonia on 31 December 2019. Less than one year later, the EU regulator approved the BioNTech-Pfizer mRNA vaccine. Moderna's version – another mRNA vaccine – followed two weeks later.φ
ΑΡΧΙΚΗ |
AKINHTH ΠΕΡΙΟΥΣΙΑ |
ΑΠΟΒΛΗΤΑ |
ΔΙΑΦΘΟΡΑ |
|ΕΛΛΗΝΙΚΗ ΙΣΤΟΡΙΑ |
ΕΝΕΡΓΕΙΑΚΑ |
θΡΑΚΗ |
ΚΟΚΚΙΝΑ ΔΑΝΕΙΑ |
ΚΥΠΡΟΣ |
ΜΕΤΑΝΑΣΤΕΥΤΙΚΟ | |
ΦΟΡΟΤΕΧΝΙΚΑ |
ΨΥΧΟΛΟΓΙΑ |
ΕΠΙΚΟΙΝΩΝΙΑ |
ΠΡΟΣΩΠΙΚΑ ΑΡΘΡΑ
Εμφάνιση αναρτήσεων με ετικέτα ΦΑΡΜΑΚΟΒΙΟΜΗΧΑΝΙΑ. Εμφάνιση όλων των αναρτήσεων
Εμφάνιση αναρτήσεων με ετικέτα ΦΑΡΜΑΚΟΒΙΟΜΗΧΑΝΙΑ. Εμφάνιση όλων των αναρτήσεων
Παρασκευή 15 Οκτωβρίου 2021
Δευτέρα 28 Αυγούστου 2017
η φαρμακευτική βιομηχανία ως οργανωμένο έγκλημα
Ο ιατρός Peter C Gøtzsche, MD εκθέτει τη φαρμακευτική βιομηχανία ως οργανωμένο έγκλημα-Και εξομολογήσεις μιας ιατρικής επισκέπτριας

Ο ιατρός Peter C Gøtzsche, MD εκθέτει τις φαρμακευτικές βιομηχανίες και το σίριαλ της δόλιας συμπεριφοράς τους, τόσο στον τομέα της έρευνας όσο και στο μάρκετινγκ όπου η ηθικά κατακριτέα περιφρόνηση για την ανθρώπινη ζωή είναι ο κανόνας....
Μεταξύ άλλων επισημαίνει: «Ο κύριος λόγος που παίρνουμε τόσα πολλά φάρμακα είναι ότι οι φαρμακευτικές εταιρείες δεν πωλούν φάρμακα, πουλάνε ψέματα σχετικά με τα φάρμακα.

Ο ιατρός Peter C Gøtzsche, MD εκθέτει τις φαρμακευτικές βιομηχανίες και το σίριαλ της δόλιας συμπεριφοράς τους, τόσο στον τομέα της έρευνας όσο και στο μάρκετινγκ όπου η ηθικά κατακριτέα περιφρόνηση για την ανθρώπινη ζωή είναι ο κανόνας....
Μεταξύ άλλων επισημαίνει: «Ο κύριος λόγος που παίρνουμε τόσα πολλά φάρμακα είναι ότι οι φαρμακευτικές εταιρείες δεν πωλούν φάρμακα, πουλάνε ψέματα σχετικά με τα φάρμακα.
Παρασκευή 18 Αυγούστου 2017
PSILOCYBIN HAS FINALLY BEEN SYNTHESIZED IN THE LAB
AFTER A HALF-CENTURY OF ATTEMPTS, PSILOCYBIN HAS FINALLY BEEN SYNTHESIZED IN THE LAB
SOURCE: MEDICAL EXPRESS

A team of researchers at Friedrich Schiller University Jena has figured how out to make psilocybin, the chemical responsible for creating hallucinations in people who consume the mushrooms that produce it naturally. In their paper published in the journal Angewandte Chemie the team describes isolating the enzymes needed to create the chemical, developing the recipe and creating psilocybin samples in their lab.
SOURCE: MEDICAL EXPRESS
A team of researchers at Friedrich Schiller University Jena has figured how out to make psilocybin, the chemical responsible for creating hallucinations in people who consume the mushrooms that produce it naturally. In their paper published in the journal Angewandte Chemie the team describes isolating the enzymes needed to create the chemical, developing the recipe and creating psilocybin samples in their lab.
Κυριακή 9 Ιουλίου 2017
Maryland’s Crackdown On Drug Price Gouging Riles Up Big Pharma
Maryland’s Crackdown On Drug Price Gouging Riles Up Big Pharma
The price-gouging bill was passed by the Democrat-led General Assembly with near unanimous support this year and only governs off-patent and generic drugs, not branded medications protected by patent laws.
By Daniel Staples |

The law applies to generic or off-patent drug makers that manufacture a medicine at least three other firms also make.
BALTIMORE — A trade group for generic drugmakers brought a federal complaint Thursday to block Maryland’s attempt of a crackdown on pharmaceutical price gouging.
The price-gouging bill was passed by the Democrat-led General Assembly with near unanimous support this year and only governs off-patent and generic drugs, not branded medications protected by patent laws.
By Daniel Staples |
The law applies to generic or off-patent drug makers that manufacture a medicine at least three other firms also make.
BALTIMORE — A trade group for generic drugmakers brought a federal complaint Thursday to block Maryland’s attempt of a crackdown on pharmaceutical price gouging.
Τετάρτη 5 Ιουλίου 2017
Το δικό τους Δελτίο Τιμών απέκτησαν τα Μη Συνταγογραφούμενα Φάρμακα (ΜΗΣΥΦΑ)
Τα ΜΗ.ΣΥ.ΦΑ. “ανεξαρτητοποιήθηκαν”
Posted By: Βασιλική Αγγουρίδηo
Το δικό τους Δελτίο Τιμών απέκτησαν τα Μη Συνταγογραφούμενα Φάρμακα (ΜΗΣΥΦΑ), κατ’ εφαρμογή της νομοθεσίας, που προβλέπει την έκδοση καταλόγου ενδεικτικών τιμών λιανικής πώλησης.
Κυριακή 25 Ιουνίου 2017
White House Plan To Reduce Drug Prices... Is To EXTEND Patents?
White House Plan To Reduce Drug Prices... Is To EXTEND Patents?
from the that's-not-how-it-works-at-all dept
While Congress is still doing its thing to try to make the US healthcare system an even bigger laughingstock around the world, the White House is apparently considering an executive order targeting high drug prices. Of course, it handed this power over to Joe Grogan, a (very recent) former lobbyist for a giant pharma company, Gilead, that has been at the center of some controversy over its highly priced drugs. Grogan is apparently leading this effort despite not having an ethics waiver, which means he's supposed to recuse himself from these discussions, rather than lead them. But, you know, that's not happening in the swampy, swampy waters of Washington DC. So just what would Grogan suggest as a way to lower drug prices? How about extending pharmaceutical patents? Yes. Extending.
from the that's-not-how-it-works-at-all dept
While Congress is still doing its thing to try to make the US healthcare system an even bigger laughingstock around the world, the White House is apparently considering an executive order targeting high drug prices. Of course, it handed this power over to Joe Grogan, a (very recent) former lobbyist for a giant pharma company, Gilead, that has been at the center of some controversy over its highly priced drugs. Grogan is apparently leading this effort despite not having an ethics waiver, which means he's supposed to recuse himself from these discussions, rather than lead them. But, you know, that's not happening in the swampy, swampy waters of Washington DC. So just what would Grogan suggest as a way to lower drug prices? How about extending pharmaceutical patents? Yes. Extending.
Σάββατο 13 Μαΐου 2017
Drugs from bugs:
Drugs from bugs: the next blockbuster medicine could be lurking inside an insectJanuary 27,
Ross Piper
For thousands of years humans turned to nature to cure and soothe their ills. Modern science built on these ancient foundations and the “natural product discovery” programmes established by pharmaceutical companies provided us with medicines that could treat cancer, infections and more.
But discovering medicines found in nature is far from straightforward. It’s hard enough to gather sufficient numbers of the useful organism, whether that be a tree root or a venomous snake, and it’s even harder to isolate the exact medicinal compound and then produce it in large quantities.
Ross Piper
For thousands of years humans turned to nature to cure and soothe their ills. Modern science built on these ancient foundations and the “natural product discovery” programmes established by pharmaceutical companies provided us with medicines that could treat cancer, infections and more.
But discovering medicines found in nature is far from straightforward. It’s hard enough to gather sufficient numbers of the useful organism, whether that be a tree root or a venomous snake, and it’s even harder to isolate the exact medicinal compound and then produce it in large quantities.
Τετάρτη 25 Ιανουαρίου 2017
Price grilled over Medicare innovation, Medicaid block grants
Αrt2275 Τετάρτη 25 Ιανουαρίου 2017
Price grilled over Medicare innovation, Medicaid block grants
By NEIL VERSEL
U.S. Health and Human
Price grilled over Medicare innovation, Medicaid block grants
By NEIL VERSEL
U.S. Health and Human
Τρίτη 24 Ιανουαρίου 2017
Αγορά Φαρμάκου: ο "μεγάλος ασθενής" της δημόσιας υγείας - 13 προτάσεις ΣΕΒ
Αrt2263 Τριτη 23 Ιανουαρίου 2017
Αγορά Φαρμάκου: ο "μεγάλος ασθενής" της δημόσιας υγείας - 13 προτάσεις ΣΕΒ
www.fotavgeia.blogspot.com
Αγορά Φαρμάκου: ο "μεγάλος ασθενής" της δημόσιας υγείας - 13 προτάσεις ΣΕΒ
www.fotavgeia.blogspot.com
Εγγραφή σε:
Αναρτήσεις (Atom)
